Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Everest Medicines Ltd. ( (HK:1952) ) has shared an update.
Everest Medicines Limited has scheduled an extraordinary general meeting (EGM) for 24 February 2026, setting the same date as the record date to determine shareholders’ eligibility to attend and vote. To facilitate this, the company will close its register of members from 16 to 24 February 2026, during which no share transfers will be registered, and has instructed unregistered shareholders to complete share transfer registrations by 4:30 p.m. on 13 February 2026 so they can participate in the EGM, with formal circulars, notices and proxy forms to be dispatched in due course.
The most recent analyst rating on (HK:1952) stock is a Hold with a HK$41.00 price target. To see the full list of analyst forecasts on Everest Medicines Ltd. stock, see the HK:1952 Stock Forecast page.
More about Everest Medicines Ltd.
Everest Medicines Limited is a biopharmaceutical company listed on the Hong Kong Stock Exchange under stock code 1952, focused on developing and commercializing innovative medicines, with its operations and shareholder base centered in Hong Kong and the broader Asian market.
Average Trading Volume: 3,633,560
Technical Sentiment Signal: Sell
Current Market Cap: HK$13.78B
See more insights into 1952 stock on TipRanks’ Stock Analysis page.